1. P183 A systematic review on outcome measures of long-term efficacy in clinical trials concerning Crohn's disease patients. (21st January 2022) Authors: Janssen, L; Creemers, R; van Bodegraven, A; Pierik, M Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P503 The risk of mild, moderate and severe infections in IBD patients: results from a prospective, multicentre, observational cohort study – PRIQ. (30th January 2023) Authors: Rezazadeh Ardabili, A; van Esser, D; Wintjens, D; Cilissen, M; Deben, D; Mujagic, Z; Russ, F; Stassen, L; van Bodegraven, A; Wong, D; Winkens, B; Jonkers, D; Romberg-Camps, M; Pierik, M Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i631 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P526 A prediction model for successful increase of adalimumab dose intervals: analysis of the pragmatic open-label randomised controlled non-inferiority LADI trial. (30th January 2023) Authors: Van Linschoten, R; Jansen, F; Pauwels, R; Smits, L; Atsma, F; Kievit, W; de Jong, D; de Vries, A; Boekema, P; West, R; Bodelier, A; Gisbertz, I; Wolfhagen, F; Romkens, T; Lutgens, M; van Bodegraven, A; Oldenburg, B; Pierik, M; Russel, M; de Boer, N Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i655 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P595 Validation of a predictive algorithm for thiopurine induced hepatotoxicity in IBD patients. (21st January 2022) Authors: Van Moorsel, F; Deben, D; Creemers, R; Winkens, B; Pierik, M; Bus, P; Simsek, M; de Boer, N; van Bodegraven, A; Wong, D Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P650 IBD care from the patient perspective: The patient's turn. (21st January 2022) Authors: Creemers, R; van der Horst, D; Raats, I; Romberg-Camps, M; Scherpenzeel, M; van Bodegraven, A Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i565 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P714 Comparison of intestinal microbiota profiles of faecal samples, rectal swabs and mucosal biopsies in patients with Inflammatory Bowel Disease. A multicentre, observational study. (21st January 2022) Authors: Van Rossen, T; van den Hoek, K; Budding, A; van Bodegraven, A Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i609 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P784 The direct healthcare costs of Crohn's disease increased over the last two decades in a Dutch population-based cohort. (16th January 2018) Authors: Lalisang, R; Wintjens, D; Romberg-Camps, M; van Bodegraven, A; Oostenbrug, L; Haans, J; Masclee, A; Jonkers, D; Pierik, M Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S507 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗